×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Calciphylaxis Market

ID: MRFR/HC/56498-HCR
200 Pages
MRFR Team
June 2025

South America Calciphylaxis Market Research Report: By Diagnosis (Deep Skin Biopsies, Blood Tests, Imaging), By Treatment (Intensive Wound Care, Medication, Therapy, Clot-Dissolving), By End User (Hospitals, Clinics, Medical Research Centers) andBy Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

South America Calciphylaxis Market Summary

Industry Developments

Recent developments in the South America Calciphylaxis Market include an increased focus on targeted therapies and innovative treatment options due to the rising incidence of chronic kidney disease in the region. Companies like Novartis AG and AbbVie Inc. are actively pursuing Research and Development initiatives aimed at better management of calciphylaxis. Additionally, the market valuation for companies such as Merck and Company and Amgen Inc. has seen growth, driven by advancements in treatment modalities and increased healthcare expenditure in South America. A notable event was the acquisition of a biotechnology firm by Fresenius Medical Care in July 2022, aimed at enhancing their product offerings for renal patients. Furthermore, in March 2023, Eli Lilly and Company announced a collaboration with local health organizations in Brazil to develop educational programs for healthcare professionals dealing with calciphylaxis cases. The South American healthcare landscape is evolving, with governments investing in public health infrastructure, bolstering the market for calciphylaxis treatments and thus encouraging partnerships among major pharmaceutical players such as Johnson and Johnson and Roche Holding AG for regional expansion initiatives.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 2018132.01(USD Million)
MARKET SIZE 2024146.93(USD Million)
MARKET SIZE 20351116.79(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 20.248% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDNovartis AG, Thermo Fisher Scientific, AbbVie Inc., GlaxoSmithKline, Celgene Corporation, Fresenius Medical Care, Baxter International, Merck & Co., Eli Lilly and Company, Amgen Inc., DaVita Inc., BristolMyers Squibb, Sanofi, Johnson & Johnson, Roche Holding AG
SEGMENTS COVEREDDiagnosis, Treatment, End User, Regional
KEY MARKET OPPORTUNITIESRising incidences of chronic kidney disease, Increased awareness among healthcare professionals, Development of targeted therapies, Growing number of research initiatives, Enhanced patient support programs
KEY MARKET DYNAMICSincreasing prevalence of kidney disease, limited treatment options available, rising awareness and diagnosis, healthcare infrastructure challenges, growing investment in research
COUNTRIES COVEREDBrazil, Mexico, Argentina, Rest of South America

Leave a Comment

FAQs

What is the projected market size of the South America Calciphylaxis Market in 2024?

The South America Calciphylaxis Market is projected to be valued at 146.93 million USD in 2024.

What is the expected market size of the South America Calciphylaxis Market by 2035?

By 2035, the South America Calciphylaxis Market is expected to reach 1116.79 million USD.

What is the projected CAGR for the South America Calciphylaxis Market between 2025 and 2035?

The expected CAGR for the South America Calciphylaxis Market is 20.248% from 2025 to 2035.

Which country holds the largest market share in the South America Calciphylaxis Market in 2024?

In 2024, Brazil is projected to hold the largest market share at 40.0 million USD.

What is the market size for Blood Tests in the South America Calciphylaxis Market in 2024?

The market size for Blood Tests in 2024 is valued at 62.93 million USD.

How much is the market for Deep Skin Biopsies expected to be worth in 2035?

The market for Deep Skin Biopsies is expected to reach 368.0 million USD by 2035.

Who are the key players in the South America Calciphylaxis Market?

Key players in the South America Calciphylaxis Market include Novartis AG, AbbVie Inc., and Merck & Co.

What is the projected market size for Argentina in the South America Calciphylaxis Market in 2035?

Argentina's market size is projected to reach 200.0 million USD by 2035.

What is the forecasted growth for the Rest of South America segment by 2035?

The Rest of South America segment is expected to grow to 366.79 million USD by 2035.

What are the expected market conditions for Imaging diagnostics within the South America Calciphylaxis Market in 2024?

The Imaging diagnostics market is projected to be valued at 36.0 million USD in 2024.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions